BARBARA PONCELET: Open Payments
NPI 1942236799 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 30 payments from 6 companies in 2025. Trend: 2023 $411 · 2024 $221 · 2025 $805
Food & beverage: $539Education: $266
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $323 |
| E.R. Squibb & Sons, L.L.C. | 11 | $209 |
| Alkermes, Inc. | 4 | $106 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| Neurocrine BioSciences, Inc. | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: COBENFY, LYBALVI, UZEDY, INGREZZA, ABILIFY ASIMTUFII, AUSTEDO XR, REXULTI, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
